Immunomedics Inc (NASDAQ:IMMU)

21.57
Delayed Data
As of 3:49pm ET
 +0.37 / +1.75%
Today’s Change
7.17
Today|||52-Week Range
22.51
+33.48%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close21.20
Today’s open21.25
Day’s range21.03 - 21.70
Volume1,252,942
Average volume (3 months)2,139,830
Market cap$3.1B
Data as of 3:49pm ET, 05/22/2018

Growth & Valuation

Earnings growth (last year)-137.10%
Earnings growth (this year)+23.36%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-4.39%
P/E ratioNM
Price/Sales298.60
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-1.06-1.67%
--Quidel Corp+1.93+3.67%
----
LNTHLantheus Holdings In...-0.13-0.88%
Data as of 3:49pm ET, 05/22/2018

Financials

Next reporting dateAugust 23, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$3.1M
Annual profit (last year)-$153.2M
Net profit margin-4,956.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Michael Pehl
Chief Financial Officer &
Vice President
Michael R. Garone
Corporate headquarters
Morris Plains, New Jersey

Forecasts